AM Investment Strategies LLC Raises Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• AM Investment Strategies LLC has increased its stock holdings in GE HealthCare Technologies Inc. by 26.5%, owning 29,085 shares valued at approximately $2.15 million.
• The company reported $1.06 earnings per share in its latest quarterly earnings, which exceeded analyst expectations, with a revenue increase of 3.5% year-over-year.
• GE HealthCare Technologies has a consensus rating of "Moderate Buy" from analysts, with a price target set at $88.40.

AM Investment Strategies LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 26.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,085 shares of the company's stock after buying an additional 6,098 shares during the quarter. AM Investment Strategies LLC's holdings in GE HealthCare Technologies were worth $2,154,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in GEHC. N.E.W. Advisory Services LLC purchased a new position in shares of GE HealthCare Technologies in the first quarter worth $25,000. Bogart Wealth LLC increased its stake in shares of GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after buying an additional 247 shares during the period. Stonebridge Financial Group LLC increased its stake in shares of GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after buying an additional 222 shares during the period. Ameriflex Group Inc. purchased a new position in GE HealthCare Technologies during the 4th quarter valued at $31,000. Finally, Olde Wealth Management LLC purchased a new position in GE HealthCare Technologies during the 1st quarter valued at $35,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on GEHC. Morgan Stanley set a $74.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Zacks Research raised shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $88.40.

GE HealthCare Technologies Trading Down 0.2%

Shares of GEHC opened at $74.60 on Wednesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a 50 day simple moving average of $74.54 and a two-hundred day simple moving average of $73.03. The firm has a market cap of $34.06 billion, a P/E ratio of 15.29, a price-to-earnings-growth ratio of 2.86 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the firm posted $1.00 EPS. The company's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.